Recombinant DNA Technology Global Market Report 2025

Recombinant DNA Technology Market Report 2023

Recombinant DNA Technology Global Market Report 2025 – By Product Type( Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing ), By Component Type( Expression System, Cloning Vector), By Application Type( Food And Agriculture, Health And Disease, Environment, Other Application Types), By End-Use Type( Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types) – Market Size, Trends, And Global Forecast 2025-2034

Name: Recombinant DNA Technology Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Recombinant DNA Technology Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Recombinant DNA Technology Global Market Report 2025

Proud Members Of

Recombinant DNA Technology Market Definition

Recombinant DNA technology refers to fusing DNA molecules from other organisms and inserting those DNA molecules into a host organism to build a new genetic combinations useful for science, medicine, agriculture, and industry. The recombinant DNA technology is used to address health issues by creating new medications and vaccines.

The main product type of recombinant DNA technology includes recombinant protein drugs, vaccines, genetically modified crops, expression systems, cell and gene therapy and gene editing. The recombinant protein drugs are used in the biochemical analysis as well as medical diagnostic reagents in human healthcare, such as antibodies, medicines, or vaccines. Recombinant protein drugs are referred to as highly potent medicines that develop faster than small molecules and are safe from off-target negative effects. The component type includes expression system and cloning vector. The recombinant DNA technology is applied in food and agriculture, health and disease, environment and other applications and used in biotechnology and pharmaceutical companies, academic and government research institutes and other end-use industries.

Recombinant DNA Technology Market Segmentation

The recombinant DNA technology market covered in this report is segmented –

1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell And Gene Therapy, Gene Editing

2) By Component Type: Expression System, Cloning Vector

3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types

4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types

Subsegments:

1) By Recombinant Protein Drugs: Hormones, Growth Factors

2) By Vaccines: Recombinant Viral Vaccines, Recombinant Bacterial Vaccines, Subunit Vaccines

3) By Genetically Modified Crops: Herbicide-Tolerant Crops, Insect-Resistant Crops, Nutritionally Enhanced Crop

4) By Expression Systems: Bacterial Expression Systems, Yeast Expression Systems, Mammalian Expression Systems

5) By Cell And Gene Therapy: Cell-Based Therapies, Gene Replacement Therapies, CAR T-Cell Therapies

6) By Gene Editing: CRISPR Or Cas9 Technologies, TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases)

Recombinant DNA Technology Market Size and growth rate 2025 to 2029: Graph

Recombinant DNA Technology Market Size 2025 And Growth Rate

The recombinant DNA technology market size has grown strongly in recent years. It will grow from $858.94 billion in 2024 to $920.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to healthcare demands, biopharmaceutical industry growth, rising investments in R&D, emergence of personalized medicine.

Recombinant DNA Technology Market Growth Forecast

The recombinant DNA technology market size is expected to see strong growth in the next few years. It will grow to $1318.72 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising chronic diseases, emerging biotech startups, increasing funding in biotech, globalization of biotech markets, consumer acceptance and education. Major trends in the forecast period include scientific advancements, gene editing advancements, cell and gene therapies, development of RNA therapeutics, therapeutic applications in rare diseases, AI and data integration.

Book your 30 minutes free consultation with our research experts

Recombinant DNA Technology Market Driver: Rising Prevalence Of Chronic Diseases To Drive Market Growth

The increasing number of chronic diseases is expected to propel the growth of the recombinant DNA technology market. Chronic diseases, which are defined as ailments that last for a year or longer, necessitate continuing medical care, restrict everyday activities, or both. Recombinant DNA technology has improved healthcare by creating biopharmaceuticals proteins used in pharmaceuticals and by replacing defective genes with healthy ones through gene therapy, aiming to cure illness. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increase in chronic diseases is driving the growth of the recombinant DNA technology market.

Recombinant DNA Technology Market Driver: Rising Development Of Genetically Modified Crops To Drive Market Growth

The increasing development of genetically modified crops is expected to propel the growth of recombinant DNA technology market going forward. Genetically modified crops refer to plants whose genetic makeup has been intentionally altered using biotechnological techniques. Recombinant DNA (rDNA) technology is employed in genetically modified (GM) crops by isolating genes that confer desired traits, constructing recombinant DNA, introducing it into host crop cells, selecting and screening for successful integration, regenerating transgenic plants, testing for trait expression, conducting field trials, obtaining regulatory approval, and ultimately commercializing crops with improved characteristics. For instance, in December 2023, according to the United States Department of Agriculture, a US-based government agency, Canada planted 11.7 million hectares of genetically engineered (GE) crops, primarily consisting of canola, soybeans, and corn. This represents a four percent increase from the previous year, driven by the expansion of canola planting areas. Therefore, the increasing development of genetically modified crops is driving the growth of recombinant DNA technology market.

Global Recombinant DNA Technology Market Major Players

Major companies operating in the recombinant DNA technology market are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline PLC, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam PLC, Horizon Discovery Group PLC, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc.

Global Recombinant DNA Technology Market Trend: Technological Advancements Driving Innovation In Recombinant DNA Technology Market

Technological advancement is a key trend in the recombinant DNA technology market. Major companies operating in the recombinant DNA technology market are focused on innovative technologies to sustain their position in the market. For instance, in August 2022, Bluebird bio, Inc., a US-based biotechnology company launched U.S. Food and Drug Administration (FDA) approved ZYNTEGLO. It is a one-time gene therapy that treats beta-thalassemia by targeting its genetic cause, offering patients the chance to become independent of regular red blood cell transfusions. It uses an ex-vivo lentiviral vector to modify patient cells and is the first FDA-approved gene therapy for this condition in the U.S. This breakthrough reduces the lifelong burden of managing beta-thalassemia.

Global Recombinant DNA Technology Market Trend: Product Innovations Transforming The Recombinant DNA Technology Market

Major companies operating in the recombinant DNA technology market are developing new vaccines to sustain their position in the market. For instance, in March 2022, Variation Biotechnologies Inc., a US-based biotechnology company launched PreHevbrio [Hepatitis B Vaccine (Recombinant)] in the United States. PreHevbrio received FDA approval in November 2021 and was subsequently added to the ACIP list of recommended adult HBV vaccines in February 2022. Administered as a 3-dose series via intramuscular injection on a 0-, 1-, and 6-month schedule, PreHevbrio contains the essential small (S), middle (pre-S2), and large (pre-S1) hepatitis B surface antigens, ensuring a robust immune response.

Recombinant DNA Technology Market Merger And Acquisition: Thermo Fisher Acquires Peprotech, Boosting Recombinant Proteins And Bioscience Reagent Portfolio

In January 2022, Thermo Fisher Scientific, a US-based scientific instrumentation supplier, reagents, consumables, and software services, acquired PeproTech for $1.85 billion. The acquisition complements Thermo Fisher's cell culture media products with PeproTech's recombinant proteins portfolio, which is expected to allow Thermo Fisher to give customers significant advantages through an integrated offering. PeproTech Inc. is a US-based developer and manufacturer of bioscience reagents known as recombinant proteins.

Regional Outlook For The Global Recombinant DNA Technology Market

North America was the largest region in the recombinant DNA technology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the recombinant DNA technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Recombinant DNA Technology Market?

The recombinant DNA technology market includes revenues earned by entities by expression systems including mammalian, bacteria, yeast, and baculovirus / insect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Recombinant DNA Technology Industry?

The recombinant DNA technology market research report is one of a series of new reports from The Business Research Company that provides recombinant DNA technology market statistics, including recombinant DNA technology industry global market size, regional shares, competitors with an recombinant DNA technology market share, detailed recombinant DNA technology market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant DNA technology industry. This recombinant DNA technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Recombinant DNA Technology Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$920.82 billion
Revenue Forecast In 2034	$1318.72 billion
Growth Rate	CAGR of 9.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell And Gene Therapy, Gene Editing 2) By Component Type: Expression System, Cloning Vector 3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types 4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types Subsegments: 1) By Recombinant Protein Drugs: Hormones, Growth Factors 2) By Vaccines: Recombinant Viral Vaccines, Recombinant Bacterial Vaccines, Subunit Vaccines 3) By Genetically Modified Crops: Herbicide-Tolerant Crops, Insect-Resistant Crops, Nutritionally Enhanced Crop 4) By Expression Systems: Bacterial Expression Systems, Yeast Expression Systems, Mammalian Expression Systems 5) By Cell And Gene Therapy: Cell-Based Therapies, Gene Replacement Therapies, CAR T-Cell Therapies 6) By Gene Editing: CRISPR Or Cas9 Technologies, TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases)
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline PLC, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam PLC, Horizon Discovery Group PLC, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Recombinant DNA Technology Market Characteristics

3. Recombinant DNA Technology Market Trends And Strategies

4. Recombinant DNA Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Recombinant DNA Technology Growth Analysis And Strategic Analysis Framework

5.1. Global Recombinant DNA Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Recombinant DNA Technology Market Growth Rate Analysis

5.4. Global Recombinant DNA Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Recombinant DNA Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Recombinant DNA Technology Total Addressable Market (TAM)

6. Recombinant DNA Technology Market Segmentation

6.1. Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant Protein Drugs

Vaccines

Genetically Modified Crops

Expression Systems

Cell and Gene Therapy

Gene Editing

6.2. Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Expression System

Cloning Vector

6.3. Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Food And Agriculture

Health And Disease

Environment

Other Application Types

6.4. Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biotechnology And Pharmaceutical Companies

Academic And Government Research Institutes

Other End-Use Types

6.5. Global Recombinant DNA Technology Market, Sub-Segmentation Of Recombinant Protein Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hormones

Growth Factors

6.6. Global Recombinant DNA Technology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant Viral Vaccines

Recombinant Bacterial Vaccines

Subunit Vaccines

6.7. Global Recombinant DNA Technology Market, Sub-Segmentation Of Genetically Modified Crops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Herbicide-Tolerant Crops

Insect-Resistant Crops

Nutritionally Enhanced Crop

6.8. Global Recombinant DNA Technology Market, Sub-Segmentation Of Expression Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bacterial Expression Systems

Yeast Expression Systems

Mammalian Expression Systems

6.9. Global Recombinant DNA Technology Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cell-Based Therapies

Gene Replacement Therapies

CAR T-Cell Therapies

6.10. Global Recombinant DNA Technology Market, Sub-Segmentation Of Gene Editing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CRISPR or Cas9 Technologies

TALENs (Transcription Activator-Like Effector Nucleases)

ZFNs (Zinc Finger Nucleases)

7. Recombinant DNA Technology Market Regional And Country Analysis

7.1. Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Recombinant DNA Technology Market

8.1. Asia-Pacific Recombinant DNA Technology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Recombinant DNA Technology Market

9.1. China Recombinant DNA Technology Market Overview

9.2. China Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Recombinant DNA Technology Market

10.1. India Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Recombinant DNA Technology Market

11.1. Japan Recombinant DNA Technology Market Overview

11.2. Japan Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Recombinant DNA Technology Market

12.1. Australia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Recombinant DNA Technology Market

13.1. Indonesia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Recombinant DNA Technology Market

14.1. South Korea Recombinant DNA Technology Market Overview

14.2. South Korea Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Recombinant DNA Technology Market

15.1. Western Europe Recombinant DNA Technology Market Overview

15.2. Western Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Recombinant DNA Technology Market

16.1. UK Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Recombinant DNA Technology Market

17.1. Germany Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Recombinant DNA Technology Market

18.1. France Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Recombinant DNA Technology Market

19.1. Italy Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Recombinant DNA Technology Market

20.1. Spain Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Recombinant DNA Technology Market

21.1. Eastern Europe Recombinant DNA Technology Market Overview

21.2. Eastern Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Recombinant DNA Technology Market

22.1. Russia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Recombinant DNA Technology Market

23.1. North America Recombinant DNA Technology Market Overview

23.2. North America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Recombinant DNA Technology Market

24.1. USA Recombinant DNA Technology Market Overview

24.2. USA Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Recombinant DNA Technology Market

25.1. Canada Recombinant DNA Technology Market Overview

25.2. Canada Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Recombinant DNA Technology Market

26.1. South America Recombinant DNA Technology Market Overview

26.2. South America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Recombinant DNA Technology Market

27.1. Brazil Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Recombinant DNA Technology Market

28.1. Middle East Recombinant DNA Technology Market Overview

28.2. Middle East Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Recombinant DNA Technology Market

29.1. Africa Recombinant DNA Technology Market Overview

29.2. Africa Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Recombinant DNA Technology Market Competitive Landscape And Company Profiles

30.1. Recombinant DNA Technology Market Competitive Landscape

30.2. Recombinant DNA Technology Market Company Profiles

30.2.1. Profacgen BioTech Corp. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Recombinant DNA Technology Market Other Major And Innovative Companies

31.1. Novo Nordisk A/S

31.2. Eli Lilly and Company

31.3. Sanofi S.A.

31.4. Merck & Co. Inc.

31.5. Biogen Inc.

31.6. GlaxoSmithKline PLC

31.7. New England Biolabs Inc.

31.8. Bayer CropScience

31.9. Thermo Fisher Scientific Inc.

31.10. F. Hoffmann-La Roche Ltd

31.11. Regeneron Pharmaceuticals Inc.

31.12. Gilead Sciences Inc.

31.13. Moderna Inc.

31.14. Vertex Pharmaceuticals Incorporated

31.15. CRISPR Therapeutics AG

32. Global Recombinant DNA Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Recombinant DNA Technology Market

34. Recent Developments In The Recombinant DNA Technology Market

35. Recombinant DNA Technology Market High Potential Countries, Segments and Strategies

35.1 Recombinant DNA Technology Market In 2029 - Countries Offering Most New Opportunities

35.2 Recombinant DNA Technology Market In 2029 - Segments Offering Most New Opportunities

35.3 Recombinant DNA Technology Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Recombinant DNA Technology Market, Sub-Segmentation Of Recombinant Protein Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Recombinant DNA Technology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Recombinant DNA Technology Market, Sub-Segmentation Of Genetically Modified Crops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Recombinant DNA Technology Market, Sub-Segmentation Of Expression Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Recombinant DNA Technology Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Recombinant DNA Technology Market, Sub-Segmentation Of Gene Editing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Profacgen BioTech Corp. Financial Performance

Table 82: Amgen Inc. Financial Performance

Table 83: Novartis International AG Financial Performance

Table 84: GenScript Biotech Corporation Financial Performance

Table 85: Pfizer Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Recombinant DNA Technology Market, Sub-Segmentation Of Recombinant Protein Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Recombinant DNA Technology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Recombinant DNA Technology Market, Sub-Segmentation Of Genetically Modified Crops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Recombinant DNA Technology Market, Sub-Segmentation Of Expression Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Recombinant DNA Technology Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Recombinant DNA Technology Market, Sub-Segmentation Of Gene Editing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Profacgen BioTech Corp. Financial Performance

Figure 82: Amgen Inc. Financial Performance

Figure 83: Novartis International AG Financial Performance

Figure 84: GenScript Biotech Corporation Financial Performance

Figure 85: Pfizer Inc. Financial Performance

Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies

Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company

What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?

How Will The Laryngoscope Market Grow In 2022?

The Business Research Company offers the single use assemblies market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dental crown and bridges market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the aircraft insulation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the aerospace 3d printing market research report 2022 with industry size, share, segments and market growth

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Culture Consumables And Equipment Global Market Report 2025 – By Product (Consumables, Instruments), By Application (Vaccination, Toxicity testing, Cancer Research, Drug Screening and Development, Recombinant Products, Stem cell technology, Regenerative Medicine, Other End Users), By End User (Industrial, Biotechnology, Agriculture, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Based Assays Global Market Report 2025 – By Product & Service (Consumables, Instruments, Services, Software), By Technology (Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies), By Application (Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cellular Telephones Global Market Report 2025 – By Product Type (Smartphone, Feature Phone), By Age-Group (Under 18 Years Old, 18-45 Years Old, 45-60 Years Old, Above 60 Years Old), By Distribution channel (OEM, Retailer, E-commerce) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Culture Global Market Report 2025 – By Type (Primary Cell Culture, Secondary Cell Culture, Cell Line), By Media (Natural, Artificial), By Applications (Stem Cell Technologies, Cancer Research, Biopharmaceutical, Tissue Engineering & Regenerative Medicine, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cellular Immunotherapy Global Market Report 2025 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell and Gene Therapy Global Market Report 2025 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cellular or Mobile Telephone Services Global Market Report 2025 – By Type (Basic Communication, Value-Added), By Service (3G Services, 4G Services, 5G Services), By End User (Manufacturing, Energy And Utilities, Media And Entertainment, It And Telecom, Transportation And Logistics, Healthcare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the recombinant dna technology market?

How will the recombinant dna technology market drivers and restraints affect the recombinant dna technology market dynamics? What forces will shape the recombinant dna technology industry going forward?

The recombinant dna technology market major growth driver - Recombinant DNA technology refers to fusing DNA molecules from other organisms and inserting those DNA molecules into a host organism to build a new genetic combinations useful for science, medicine, agriculture, and industry. The recombinant DNA technology is used to address health issues by creating new medications and vaccines. . For further insights on the recombinant dna technology market, request a sample here

What is the forecast market size or the forecast market value of the recombinant dna technology market?

The recombinant DNA technology market size has grown strongly in recent years. It will grow from $858.94 billion in 2024 to $920.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to healthcare demands, biopharmaceutical industry growth, rising investments in R&D, emergence of personalized medicine. The recombinant DNA technology market size is expected to see strong growth in the next few years. It will grow to $1318.72 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising chronic diseases, emerging biotech startups, increasing funding in biotech, globalization of biotech markets, consumer acceptance and education. Major trends in the forecast period include scientific advancements, gene editing advancements, cell and gene therapies, development of RNA therapeutics, therapeutic applications in rare diseases, AI and data integration. For further insights on the recombinant dna technology market, request a sample here

How is the recombinant dna technology market segmented?

The recombinant dna technology market is segmented
1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell And Gene Therapy, Gene Editing
2) By Component Type: Expression System, Cloning Vector
3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types
4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types Subsegments:
1) By Recombinant Protein Drugs: Hormones, Growth Factors
2) By Vaccines: Recombinant Viral Vaccines, Recombinant Bacterial Vaccines, Subunit Vaccines
3) By Genetically Modified Crops: Herbicide-Tolerant Crops, Insect-Resistant Crops, Nutritionally Enhanced Crop
4) By Expression Systems: Bacterial Expression Systems, Yeast Expression Systems, Mammalian Expression Systems
5) By Cell And Gene Therapy: Cell-Based Therapies, Gene Replacement Therapies, CAR T-Cell Therapies
6) By Gene Editing: CRISPR Or Cas9 Technologies, TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases)For further insights on the recombinant dna technology market, request a sample here

Which region has the largest share of the recombinant dna technology market? What are the other regions covered in the report?

North America was the largest region in the recombinant DNA technology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the recombinant dna technology market, request a sample here.

Who are the major players in the recombinant dna technology market?

What are the key trends in the recombinant dna technology market?

Major trend in the recombinant dna technology market - Technological Advancements Driving Innovation In Recombinant DNA Technology Market. For further insights on the recombinant dna technology market, request a sample here.

What are the major opportunities in the recombinant dna technology market? What are the strategies for the recombinant dna technology market?

For detailed insights on the major opportunities and strategies in the recombinant dna technology market, request a sample here.

How does the recombinant dna technology market relate to the overall economy and other similar markets?

For detailed insights on recombinant dna technology market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the recombinant dna technology industry?

For detailed insights on the mergers and acquisitions in the recombinant dna technology industry, request a sample here.

What are the key dynamics influencing the recombinant dna technology market growth? SWOT analysis of the recombinant dna technology market.

For detailed insights on the key dynamics influencing the recombinant dna technology market growth and SWOT analysis of the recombinant dna technology industry, request a sample here.